Envejecimiento, Neurodegeneración y Salud Mental

Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease

1. Dafsari HS, Silverdale M, Strack M, Rizos A, Ashkan K, Mahlstedt P, Sachse L, Steffen J, Dembek TA, Visser-Vandewalle V, Evans J, Antonini A, Martinez-Martin P, Ray-Chaudhuri K, Timmermann L. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease. Mov Disord 2018;33(3):421-30. [doi].PM:29465787. FI: 8,324; Q1

PUBMED DOI

Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence

2. García López FJ, Ruiz-Tovar M, Almazán-Isla J, Alcalde-Cabero E, Calero M, de Pedro-Cuesta J. Risk of transmission of sporadic Creutzfeldt-Jakob disease by surgical procedures: systematic reviews and quality of evidence. Euro Surveill 2017;22(43). [doi].PM:29090678. FI: 7,127; Q1

PUBMED DOI

Validation study of the hoehn and yahr scale included in the MDS-UPDRS

3. Martinez-Martin P, Skorvanek M, Rojo-Abuin JM, Gregova Z, Stebbins GT, Goetz CG. Validation study of the hoehn and yahr scale included in the MDS-UPDRS. Mov Disord 2018;33(4):651-2. [doi].PM:29322548. FI: 8,324; Q1

PUBMED DOI

The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States

4. Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, Sail K. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Mov Disord 2018. [doi].PM:30589953. FI: 8,324; Q1

PUBMED DOI

Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease

5. Martinez-Martin P, Rizos AM, Wetmore JB, Antonini A, Odin P, Pal S, Sophia R, Carroll C, Martino D, Falup-Pecurariu C, Kessel B, Andrews T, Paviour D, Trenkwalder C, Chaudhuri KR. Relationship of Nocturnal Sleep Dysfunction and Pain Subtypes in Parkinson's Disease. Mov Disord Clin Pract 2019;6(1):57-64. doi: 10.1002/mdc3.12694;doi: 10.1002/mdc3.12694.. FI: 8,324; Q1

PUBMED DOI

Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations

6. Mestre TA, Busse M, Davis AM, Quinn L, Rodrigues FB, Burgunder JM, Carlozzi NE, Walker F, Ho AK, Sampaio C, Goetz CG, Cubo E, Martinez-Martin P, Stebbins GT. Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations. Mov Disord Clin Pract 2018;5(4):361-72. [doi];MDC312617 [pii].PM:30363510. FI: 8,324; Q1

PUBMED DOI

Rating scales for cognition in Huntington's disease: Critique and recommendations

7. Mestre TA, Bachoud-Levi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P. Rating scales for cognition in Huntington's disease: Critique and recommendations. Mov Disord 2018;33(2):187-95. [doi].PM:29278291. FI: 8,324; Q1

PUBMED DOI

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study

8. Schmitt E, Krack P, Castrioto A, Klinger H, Bichon A, Lhommee E, Pelissier P, Fraix V, Thobois S, Moro E, Martinez-Martin P. The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study. Mov Disord Clin Pract 2018;5(3):265-72. [doi];MDC312607 [pii].PM:30363450. FI: 8,324; Q1

PUBMED DOI

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations

9. Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van DE, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P. Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Mov Disord 2018;33(2):208-18. [doi].PM:29168899. FI: 8,324; Q1

PUBMED DOI

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect

10. Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van DE, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P. Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect. Mov Disord 2018;33(3):499-500. [doi].PM:29460975. FI: 8,324; Q1

PUBMED DOI

Investigación